HPTA
Project Report in GraSPP on “Health Policy & Technology Assessment Research and Training Program 2017 – 2021”
Health Technology Assessment International Symposium
Project Report in GraSPP on “Health Policy & Technology Assessment Research and Training Program 2017 – 2021”
and “International Joint Research on COVID-19”
Date & Time: December 21, 2022
Part I 16:30 – 18:40 (JST)
Part II 20:20 – 22:00 (JST)
Venue: Virtual Online Meeting
Organizer: Graduate School of Public Policy (GraSPP), The University of Tokyo
Co-Sponsor: The Canon Institute for Global Studies (CIGS)
Auspice: Musashino Institute for Global Affairs, Musashino University
Please register here
Program
Part I “Project Report on Health Policy & Technology Assessment Research and Training Program 2017-2021”
The research and education project on health policy and technology assessment (HPTA) was initiated in April 2017 in the Graduate School of Public Policy (GraSPP), University of Tokyo. The HPTA was designed to collaborate with the MHLW officers and the affiliated experts who have responsibility for a new policy of health technology assessment (HTA), which was provisionally introduced in 2016 and institutionalized in 2019. The first part of this symposium reports the achievement of the HPTA project reviewing the past six years from 2017 to 2022 and seeks future directions for Japan, learning global challenges from an European expert of HTA.
16:30-16:40 Opening Remarks
Hideaki Shiroyama, Professor, Graduate School of Public Policy, The University of Tokyo
16:40-16:50 Co-Sponsor’s Remarks
Toshihiko Fukui, President, The Canon Institute for Global Studies
16:50-17:15 “Report on Health Policy & Technology Assessment Research and Training Program 2017 – 2021“
Isao Kamae, Project Professor, GraSPP, The University of Tokyo
17:15-17:30 “Public-private partnership on HTA education in GraSPP 2017–2021”
Makoto Kobayashi Director and Chief Operating Officer, Crecon Medical Assessment, Japan
17:30-18:30 “Global Challenges of HTA in Comparison with Germany, France and Japan“
Jörg Mahlich, Market Access & Government Affairs Lead, Miltenyi Biomedicine, and Research Affiliate, Düsseldorf Institute for Competition Economics (DICE) Germany
18:30-18:40 Dean’s Remarks
Keisuke Iida, Dean, GraSPP, The University of Tokyo
18:40-20:20 Intermission
Part II “Project Report on International Joint Research on COVID-19”
The objectives of this session are to introduce the International Joint Study on Public Health Economics of the COVID-19 Pandemic with the research grant, “Hitachi Fund Support for Research Related to Infectious Diseases,” which was initiated on the platform of GraSPP, the University of Tokyo in December 2021. Three groups with international experts in health economics and outcomes research in Europe, Asia, and North-America discuss the gap between myth and truth experienced during the pandemic so far, and share the lessons learned, focusing on public health economics, testing strategies, and simulation impact of vaccinations.
20:20-20:25 Primary Investigator’s Remarks
Akio Onishi, Visiting Professor, GraSPP, The University of Tokyo
20:25-20:55 Asia Group progress report: “Evidence-based testing strategies”
Isao Kamae, Project Professor, GraSPP, The University of Tokyo
Makoto Kobayashi, Director and Chief Operating Officer, Crecon Medical Assessment, Japan
Ryo Watanabe, Associate Professor, Kanagawa University of Human Services, Japan
Chee Jen Chang, Distinguished Professor, Chang Gung University, Taiwan
Hwee-Lin Wee, Associate Professor, National University of Singapore
20:55-21:25 Europe Group progress report: “Public health economics”
Ulf Persson, Senior adviser and Professor, Swedish Institute for Health Economics, Sweden et al.
Pierre-Y Geoffard, Professor, Paris School of Economics, France
Jörgen Möller, Vice President, Evidera, Sweden
21:25-21:55 North America group progress report “Simulation and the forecast impact of vaccination”
Jaime Caro, Chief Scientist, Evidera, Professor, McGill University, Canada, and Professor in Practice at London School of Economics, UK
Debra Schaumberg, Professor of Ophthalmology and Visual Sciences, University of Utah, USA
Jack Ishak, Vice President, Evidera, Canada
21:55-22:00 Closing Remarks
Isao Kamae, Project Professor, GraSPP, The University of Tokyo
22:00 Adjournment